SONORX Drug Patent Profile
✉ Email this page to a colleague
When do Sonorx patents expire, and what generic alternatives are available?
Sonorx is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in SONORX is simethicone-cellulose. Additional details are available on the simethicone-cellulose profile page.
Summary for SONORX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
DailyMed Link: | SONORX at DailyMed |
US Patents and Regulatory Information for SONORX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | SONORX | simethicone-cellulose | SUSPENSION;ORAL | 020773-001 | Oct 29, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |